financetom
Business
financetom
/
Business
/
QuantumScape Insider Sold Shares Worth $1,907,309, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QuantumScape Insider Sold Shares Worth $1,907,309, According to a Recent SEC Filing
Sep 9, 2025 12:33 AM

03:13 AM EDT, 09/09/2025 (MT Newswires) -- Timothy Holme, Chief Technology Officer, on September 04, 2025, sold 244,519 shares in QuantumScape ( QS ) for $1,907,309. Following the Form 4 filing with the SEC, Holme has control over a total of 1,422,060 Class A common shares of the company, with 1,422,060 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1811414/000183424925000005/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: JPMorgan to Leave Net-Zero Banking Alliance
Update: JPMorgan to Leave Net-Zero Banking Alliance
Jan 7, 2025
10:35 AM EST, 01/07/2025 (MT Newswires) -- (Updates throughout with JPMorgan's ( JPM ) comments.) JPMorgan ( JPM ) is leaving climate group Net-Zero Banking Alliance, a company spokesperson told MT Newswires Tuesday. We will continue to work independently to advance the interests of our firm, our shareholders and our clients and remain focused on pragmatic solutions to help further...
NEO Battery Materials Launches New Product Line With
NEO Battery Materials Launches New Product Line With "Breakthrough" Battery Capacity
Jan 7, 2025
10:30 AM EST, 01/07/2025 (MT Newswires) -- NEO Battery Materials ( NBMFF ) on Tuesday announced the launch of an advanced high-performance silicon anode product with breakthrough battery capacity. The NBMSiDE P-300 product line showed a 43% to 130% improvement in initial battery capacity over traditional graphite anodes with less material used, the company said. NEO, which has submitted a...
Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia
Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia
Jan 7, 2025
10:34 AM EST, 01/07/2025 (MT Newswires) -- Rezolute ( RZLT ) said Tuesday it has received the US Food and Drug Administration's Breakthrough Therapy designation for its ersodetug monoclonal antibody to treat hypoglycemia due to congenital hyperinsulinism. The regulator's decision was based on the company's phase 2b trial of ersodetug in patients with congenital hyperinsulinism, which safely showed significant improvements...
Actuate Therapeutics Gets Orphan Medicinal Product Label for Elraglusib in EU
Actuate Therapeutics Gets Orphan Medicinal Product Label for Elraglusib in EU
Jan 7, 2025
10:34 AM EST, 01/07/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Tuesday that the European Medicines Agency has granted orphan medicinal product designation to elraglusib for the treatment of pancreatic ductal adenocarcinoma. The company said the designation is granted to therapies intended for the treatment of life-threatening diseases that affect no more than two in 10,000 people in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved